Humanwell Healthcare (600079.SH): HW241045 tablets approved for clinical trials of drugs.

date
05/08/2025
avatar
GMT Eight
People's Pharmaceutical Group (600079.SH) announced that its wholly-owned subsidiary, Wuhan People's Pharmaceuticals Innovation Drug Research Center Co., Ltd...
Healthcare company Humanwell Healthcare (600079.SH) announced that its wholly-owned subsidiary, Wuhan Humanwell Innovation Drug Research Center Co., Ltd., has recently received approval from the National Medical Products Administration for HW241045 tablets to conduct clinical trials. HW241045 tablets are used for the treatment of idiopathic pulmonary fibrosis, and currently there are no drugs with the same target approved for marketing globally.